TCM
TXMD icon

Traynor Capital Management’s TherapeuticsMD TXMD Stock Holding History

Traynor Capital Management’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-7,360
Closed -$139K – 215
2022
Q1 		$139K Hold
7,360
– – 0.02% 180
2021
Q4 		$130K Hold
7,360
– – 0.02% 200
2021
Q3 		$272K Hold
7,360
– – 0.04% 148
2021
Q2 		$412K Hold
7,360
– – 0.06% 126
2021
Q1 		$493K Buy
7,360
+5,530
+302% +$433K 0.08% 108
2020
Q4 		$110K Buy
1,830
+1,630
+815% +$111K 0.02% 151
2020
Q3 		$14K Buy
+200
New +$15.9K ﹤0.01% 153
2018
Q1 		– Sell
-490
Closed -$147K – 191
2017
Q4 		$147K Sell
490
-36
-7% -$10K 0.06% 164
2017
Q3 		$134K Buy
526
+70
+15% +$20.2K 0.06% 157
2017
Q2 		$123K Buy
456
+56
+14% +$14K 0.06% 152
2017
Q1 		$96K Sell
400
-150
-27% -$46.4K 0.05% 148
2016
Q4 		$155K Buy
550
+150
+38% +$46.5K 0.1% 119
2016
Q3 		$119K Buy
400
+70
+21% +$25.6K 0.08% 119
2016
Q2 		$142K Hold
330
– – 0.11% 120
2016
Q1 		$105K Buy
330
+8
+2% +$2.73K 0.08% 109
2015
Q4 		$166K Hold
322
– – 0.12% 124
2015
Q3 		$94K Sell
322
-204
-39% -$72.5K 0.08% 118
2015
Q2 		$206K Sell
526
-50
-9% -$17.6K 0.17% 121
2015
Q1 		$174K Buy
576
+316
+122% +$77.1K 0.17% 111
2014
Q4 		$57K Buy
+260
New +$53.6K 0.07% 109

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Traynor Capital Management's TXMD Position: Q2 2022 in Review

Traynor Capital Management sold out of TherapeuticsMD (TXMD) in Q2 2022, closing a stake of 7,360 shares — an estimated $139K sold.

Traynor Capital Management first reported a position in TXMD in Q4 2014 and held it in 20 quarters. The position peaked at $493K in Q1 2021. 53 funds tracked by Wall St. Rank hold TXMD as of Q2 2022.

  • Traynor Capital Management reported no remaining TherapeuticsMD position as of Q2 2022 after selling out during the quarter.
  • Traynor Capital Management sold 7,360 TherapeuticsMD shares in Q2 2022, an estimated $139K.
  • Traynor Capital Management first reported a position in TherapeuticsMD in Q4 2014 and held it in 20 quarters.
  • Traynor Capital Management's TherapeuticsMD position peaked at $493K in Q1 2021.
  • 53 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2022.

Based on Traynor Capital Management's 13F filing for Q2 2022, filed 28 Jul 2022.